The CFTR gene gives cells instructions for a channel that moves salt and water across the lining of the lungs, pancreas, gut, and other organs. This gene helps your body keep mucus and digestive fluids thin enough to move easily. When the gene does not work properly, mucus can become thick and sticky, which can lead to cystic fibrosis or related problems such as sinus disease, digestive trouble, and some forms of male infertility. CFTR became widely known through public awareness of cystic fibrosis and major advances in treatment.
What is a gene?
Genes are sections of DNA that carry instructions your cells use to make molecules or manage processes in the body. Some genes provide the directions for producing proteins, which are the working parts of cells. Others mostly help regulate when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, or medications. For a more detailed look at this topic, you can find more in the LearnHub.
Overview
CFTRGene function
What if the gene works
The CFTR gene makes a protein that moves chloride across cell surfaces. This helps control salt and water balance, keeping mucus, sweat, and digestive juices at the right consistency.
Risk
What if the gene does not work
When the CFTR gene does not work well, thick, sticky mucus can affect the lungs, pancreas, and gut, causing cystic fibrosis. Milder or more severe variants can change which organs are involved and how early symptoms appear, including fertility problems.
Treatment
What does that mean for your treatment
Pathogenic variants in the CFTR gene can guide use of CFTR modulators such as ivacaftor or elexacaftor/tezacaftor/ivacaftor. The exact CFTR variant matters because some variants are responsive to these medicines and others are not. In practice, CFTR status can directly shape drug choice and the chance of benefit.
Conditions associated with CFTR
Gene function
What if the gene works
Breathing, digestion, and sweating all depend in part on balanced movement of salt and water. The CFTR gene helps control this flow at the surface of cells in the lungs, pancreas, intestines, and sweat glands. When it works normally, mucus stays easier to clear and digestive juices and sweat are balanced.
The CFTR gene gives cells instructions for a channel that lets chloride, a salt particle, move across the cell surface. This controlled flow is a key part of normal fluid handling in the airways, gut, pancreas, and sweat glands.
As chloride moves, water tends to follow. This is a big part of what the CFTR gene does in the body each day, keeping surface fluids at the right thickness and helping mucus stay easier to clear.
CFTR also helps move bicarbonate, a natural substance that balances acidity. This supports the right chemical mix in mucus and digestive juices, especially in the pancreas and intestines.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These differences are common and are part of normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not cause any noticeable effect and simply represent natural genetic variation. In some cases, however, a variant can affect how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the CFTR gene can change how much CFTR protein is made, whether it folds into the right shape, reaches the cell surface, or opens well enough to move salt and water. This is how CFTR gene variants affect protein function at a basic level. Some variants leave partial activity, while more severe variants lead to little or no working protein. That difference often shapes whether cystic fibrosis features appear later and milder or earlier and more strongly.
How variants are linked to conditions
Pathogenic variants in the CFTR gene cause cystic fibrosis and can also lead to CFTR-related conditions such as congenital bilateral absence of the vas deferens, a recognized cause of male infertility. Some people with certain CFTR gene variants develop recurrent pancreatitis or bronchiectasis without having the full picture of cystic fibrosis. Carrying one CFTR variant usually means carrier status, while disease typically involves two pathogenic variants.
A variant is not necessarily a diagnosis
Variants in genes are a routine part of being human and are common across the population. Most have no direct impact on health and simply reflect natural human diversity. For many genes, carrying a variant connected with a condition suggests a possible association rather than a definite diagnosis, especially when more than one gene and environmental factors are involved. In some instances, however, a single well-characterized variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For CFTR, risk is driven mainly by the variants inherited, especially whether one or both copies of the gene have a disease-causing change. Family history and, for future children, whether both parents carry a CFTR variant matter most; smoking, lung infections, and poor nutrition do not change the inherited risk but can make health problems worse.
Inheritance of CFTR variants
Variants in the CFTR gene are usually inherited in an autosomal recessive pattern. That means a person typically needs to inherit two disease-causing CFTR variants, one from each parent, to have cystic fibrosis or a related CFTR condition. Parents who each carry one variant are often unaffected carriers, and with each pregnancy there is a 25% chance their child will inherit both variants, a 50% chance the child will be a carrier, and a 25% chance the child will inherit neither variant. The CFTR inheritance pattern affects sons and daughters equally.
What does my CFTR result mean for my family?
A CFTR result can matter for close relatives because family members may also carry the same gene change, even if they do not have symptoms. Brothers, sisters, and children may want to learn whether they are carriers, especially if they are planning a pregnancy. If someone in the family has cystic fibrosis or a related CFTR condition, relatives may also share the same genetic cause.
Genetic information
Genetic testing
How you find out about variants
Testing for the CFTR gene usually uses a blood, saliva, or cheek swab sample to look for variants linked to cystic fibrosis or carrier status. To understand how CFTR genetic testing works, the lab reads selected parts of the gene or the full gene and compares your DNA sequence with the usual version to identify variants.
When should I consider getting a genetic test?
You may consider CFTR testing if cystic fibrosis runs in your family, if a partner is known to carry a CFTR change, or if you are planning a pregnancy. It can also help explain repeated chest infections, poor weight gain, repeated inflammation of the pancreas, or some forms of male infertility.
A genetic result is only one part of your health story
Genetic test findings can be informative, but how much they reveal varies by the condition and the specific type of variant. Over time, factors such as lifestyle, environment, age, and medical history also affect how the body functions. In some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result can provide a clear answer. In areas like medication response, genetic results may also help put personal experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Some variants in the CFTR gene can determine whether certain cystic fibrosis medicines called CFTR modulators are likely to work, because these treatments target specific changes in the CFTR protein. That helps explain why the same medicine may benefit one person more than another, even when both have cystic fibrosis. Genetic differences that affect how a drug works in the body are common and can influence both treatment benefit and the chance of side effects. A gene result is one part of the picture, alongside age, other medicines, and overall health.
What is Pharmacogenetics?
Pharmacogenetics examines how inherited genetic differences can affect the way a person responds to medication. It focuses on gene drug relationships to help explain why the same treatment may work differently in different people. With many medicines, genes can influence how powerfully a drug works or how the body handles it. This understanding can support treatment choices that are more informed and more tailored to the individual. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the CFTR gene
When should I seek medical advice?
If you or your child has cystic fibrosis and treatment with a CFTR modulator is being planned or changed, it is worth discussing your CFTR results with the care team. Some cystic fibrosis medicines that target the CFTR protein are used only for certain CFTR changes, so the gene result can affect which treatment is likely to help. Bring it up if treatment is not working as expected or before switching therapies.
History
Cystic fibrosis was recognized as a distinct inherited condition long before the CFTR gene was found. In 1989, researchers identified the CFTR gene, a major milestone that helped explain the cause of cystic fibrosis at the DNA level. From these first observations, research expanded steadily. The discovery became a landmark in human genetics because it showed how gene mapping could pinpoint the cause of a common inherited condition. Over time, this led to more accurate genetic testing, carrier screening, and a clearer understanding of why symptoms can vary so much from one person to another. The CFTR gene remains one of the best known examples of how gene discovery changed diagnosis and care for families affected by an inherited condition.